546PTUMOUR SHRINKAGE AND RESPONSE OUTCOMES DURING SECOND-LINE PANITUMUMAB (PMAB) + FOLFIRI VS FOLFIRI TREATMENT.
暂无分享,去创建一个
F. Lordick | C. Punt | M. Ducreux | M. Peeters | T. Price | A. Cervantes | T. André | A. Sobrero | J. Terwey | R. Koukakis | E. van Custem